Log In
Print
BCIQ
Print
Print this Print this
 

AEZS-136

  Manage Alerts
Collapse Summary General Information
Company Aeterna Zentaris Inc.
DescriptionDual MAP kinase 3 (MAPK3; ERK-1)/MAP kinase 1 (MAPK1; ERK-2) and phosphoinositide 3-kinase (PI3K) inhibitor
Molecular Target MAP kinase 3 (MAPK3) (ERK-1) ; Phosphoinositide 3-kinase (PI3K)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today